Radiation, Tamoxifen and Breast Cancer

In a December 7, 2010, news release Dr. Lauren Cassell, chief of breast surgery at Lenox Hill Hospital in New York City announced that a three-nation study on localized breast cancer revealed that:

1. The drug tamoxifen greatly reduced the risk of the recurrence of localized cancer and decreased the risk of new cancer in the other breast by more than 65%;

2. Radiation after surgery greatly reduced the risk of invasive cancer in the same breast.